Hydroxyurea for Stroke Prevention in Children With Sickle Cell Disease in Sub-Saharan Africa
Phase of Trial: Phase III
Latest Information Update: 31 Mar 2017
At a glance
- Drugs Hydroxycarbamide (Primary)
- Indications Stroke
- Focus Therapeutic Use
- Acronyms SPRINT
- 24 Mar 2017 Status changed from not yet recruiting to recruiting.
- 02 Nov 2016 Planned initiation date changed from 1 Jul 2016 to 1 Dec 2016.
- 18 Feb 2016 New trial record